SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-411366
Filing Date
2014-11-13
Accepted
2014-11-13 17:20:11
Documents
18
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d806302d10q.htm 10-Q 640402
2 EX-31.1 d806302dex311.htm EX-31.1 8504
3 EX-31.2 d806302dex312.htm EX-31.2 8500
4 EX-32.1 d806302dex321.htm EX-32.1 4206
11 GRAPHIC g806302dsp_017.jpg GRAPHIC 39065
12 GRAPHIC g806302dsp_019.jpg GRAPHIC 39711
13 GRAPHIC g806302dsp_021a.jpg GRAPHIC 50409
14 GRAPHIC g806302dsp_021b.jpg GRAPHIC 11029
15 GRAPHIC g806302dsp_022.jpg GRAPHIC 11812
16 GRAPHIC g806302dsp_024.jpg GRAPHIC 66157
17 GRAPHIC g806302dsp_025a.jpg GRAPHIC 12090
18 GRAPHIC g806302dsp_025b.jpg GRAPHIC 43124
  Complete submission text file 0001193125-14-411366.txt   3400654

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20140930.xml EX-101.INS 316381
6 XBRL TAXONOMY EXTENSION SCHEMA ebio-20140930.xsd EX-101.SCH 27417
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebio-20140930_cal.xml EX-101.CAL 39793
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebio-20140930_def.xml EX-101.DEF 98258
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebio-20140930_lab.xml EX-101.LAB 263016
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebio-20140930_pre.xml EX-101.PRE 175448
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 141219342
SIC: 2834 Pharmaceutical Preparations